Last reviewed · How we verify
NCT07390006
Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS)
NA trial testing Innovative Care Approach in Acute Coronary Syndrome/ Myocardial Infarction in 80 participants. Not yet recruiting.
31 August 2026
Quick facts
| Lead sponsor | Mahidol University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 80 |
| Start date | 10 March 2026 |
| Primary completion | 31 August 2026 |
| Estimated completion | 10 January 2027 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Innovative Care Approach
- Usual Post-Acute Coronary Syndrome Care
Conditions studied
- Acute Coronary Syndrome/ Myocardial Infarction — all drugs for Acute Coronary Syndrome/ Myocardial Infarction →
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Mahidol University
Who can join
60 and older, any sex, with Acute Coronary Syndrome/ Myocardial Infarction or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effectiveness of an innovative care approach that integrates face-to-face education, motivational counseling, and mobile health (mHealth) support delivered via the LINE application among Thai older adults following acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). The intervention aims to support post-discharge recovery by promoting healthy behaviors, improving health status, and enhancing patient satisfaction with care. The primary objective is to assess the effect of the intervention on patient-reported outcomes, including healthy behaviors, health status, and patient satisfaction. Secondary objectives include evaluating unplanned hospital visits during a 12-week follow-up period and exploring participants' experiences, motivation, and engagement with the innovative care approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07390006
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mahidol University trials
Trials by the same sponsor.
- NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
- NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
- NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
- NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
- NCT07433972 — Changes in Hemodynamic Response Following Transcranial Electrical Stimulation in Sroke Individuals · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07390006 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mahidol University
- Last refreshed: 9 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07390006.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing